substance p has been researched along with Myoclonic Jerk in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gunes, H; Kilinc, E | 1 |
| Drago, J; Finkelstein, DI; Kola, I; Lakso, M; Lawrence, AJ; McManus, JF; Natoli, AL; Padungchaichot, P; Sumarsono, SH; Westphal, H; Wong, JY; Wreford, N | 1 |
2 other study(ies) available for substance p and Myoclonic Jerk
| Article | Year |
|---|---|
Modulatory effects of neuropeptides on pentylenetetrazol-induced epileptic seizures and neuroinflammation in rats.
Topics: Animals; Biomarkers; Calcitonin Gene-Related Peptide; Convulsants; Disease Models, Animal; Ghrelin; Inflammation; Interleukin-1beta; Male; Myoclonus; Neuropeptides; Pentylenetetrazole; Peptide Hormones; Random Allocation; Rats, Wistar; Seizures; Substance P; Time Factors; Vasoactive Intestinal Peptide | 2019 |
Targeted expression of a toxin gene to D1 dopamine receptor neurons by cre-mediated site-specific recombination.
Topics: Animals; Apoptosis; Basal Ganglia; Diphtheria Toxin; Enkephalins; Gene Expression Regulation, Enzymologic; Glial Fibrillary Acidic Protein; Gliosis; In Situ Hybridization; In Situ Nick-End Labeling; Integrases; Mice; Mice, Transgenic; Microscopy, Electron; Movement Disorders; Myoclonus; Neurons; Parkinson Disease, Secondary; Phenotype; Radioligand Assay; Receptors, Dopamine D1; RNA, Messenger; Substance P; Viral Proteins | 1998 |